Clearance Summary
RELI REDIDIOX Dyed, RELI REDIDIOX, RELI REDIDIOX Undyed received FDA 510(k) clearance under submission number K161737, sponsored by Myco Medical. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2017-03-02.
- Submission: K161737
- Applicant / Sponsor: Myco Medical
- Clearance pathway: Abbreviated
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4840
- Decision date: 2017-03-02
Classification & Regulation
This clearance is catalogued under FDA product code NEW and 21 CFR 878.4840, within the General, Plastic Surgery review panel as a Class II device.